{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:21:46Z","timestamp":1790821306328,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T00:00:00Z","timestamp":1677974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The clinical characteristics of patients with the comorbidities of hypertension and coronary artery disease (HT-CAD) and atrial fibrillation (AF) are largely unknown. This study aimed to investigate the prevalence of AF in patients with HT-CAD and clinical characteristics of patients with both HT-CAD and AF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This cross-sectional study was conducted in Chinese People's Liberation Army General Hospital in Beijing, China, and included 20,747 inpatients with HT-CAD with or without AF from August 2008 to July 2018. We examined the overall prevalence, clinical characteristics, comorbidity profiles, treatment patterns, and blood pressure (BP) control of patients with both HT-CAD and AF. Multivariate logistic regression was used to investigate the associations of cardiovascular risk factors with AF in patients with HT-CAD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The overall prevalence of AF in patients with HT-CAD was 4.87% (1011\/20,747), and this increased with age; to be specific, the prevalence in women and men increased from 0.78% (2\/255) and 1.02% (26\/2561) at the age of &lt;50 years to 8.73% (193\/2210) and 10.28% (298\/2900) at the age of \u226570 years, respectively. HT-CAD patients who had AF had a higher prevalence of cardiovascular-related comorbidities than those without AF. Multivariate logistic regression showed that age, gender (male), body mass index, heart failure, and chronic kidney disease were independently associated with the risk of AF in patients with HT-CAD. For those with both HT-CAD and AF, 73.49% (743\/1011) had a CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score of \u22654, and only about half of them had the BP controlled at &lt;140\/90 mmHg, which indicated a high risk of thromboembolism and stroke. The use of oral anticoagulation increased during the study period (10.00% [20\/200] in 2008 to 2011 <jats:italic toggle=\"yes\">vs.<\/jats:italic> 30.06% [159\/529] in 2015 to 2018, <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>&lt;\u200a0.01), but remained at a relatively low level.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>AF is highly prevalent among patients with HT-CAD. Patients with both HT-CAD and AF have a higher prevalence of cardiovascular-related comorbidities, lower BP control rate, and lower use of oral anticoagulation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002471","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T05:01:01Z","timestamp":1678770061000},"page":"588-595","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018"],"prefix":"10.1097","volume":"136","author":[{"given":"Qian","family":"Xin","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"},{"name":"Chinese People's Liberation Army Medical School, Beijing 100853, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Yun","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"},{"name":"Chinese People's Liberation Army Medical School, Beijing 100853, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Hou","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"},{"name":"Chinese People's Liberation Army Medical School, Beijing 100853, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Li","sequence":"additional","affiliation":[{"name":"The School of Medicine, Nankai University, Tianjin 300071, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"},{"name":"Chinese People's Liberation Army Medical School, Beijing 100853, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100048, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,5]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990\u20132015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"R4-20250602","first-page":"573","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"35","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/heartjnl-2020-317915","article-title":"Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China","volume":"107","author":"Du","year":"2021","journal-title":"Heart"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.phrs.2017.10.007","article-title":"Atrial fibrillation and arterial hypertension","volume":"128","author":"Kallistratos","year":"2018","journal-title":"Pharmacol Res"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.311402","article-title":"Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies","volume":"122","author":"Verdecchia","year":"2018","journal-title":"Circ Res"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CRD.0000000000000006","article-title":"Inflammation in coronary artery disease","volume":"22","author":"Christodoulidis","year":"2014","journal-title":"Cardiol Rev"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2018.05.015","article-title":"The disease burden of atrial fibrillation in China from a national cross-sectional survey","volume":"122","author":"Wang","year":"2018","journal-title":"Am J Cardiol"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2008.05.042","article-title":"Epidemiology, risk factors for stroke, and management of atrial fibrillation in China","volume":"52","author":"Hu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.jacc.2019.04.036","article-title":"Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International","volume":"73","author":"Du","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/CM9.0000000000001515","article-title":"A simple and easily implemented risk model to predict 1-year ischemic stroke and systemic embolism in Chinese patients with atrial fibrillation","volume":"134","author":"Jiang","year":"2021","journal-title":"Chin Med J"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","article-title":"Patients with atrial fibrillation and coronary artery disease\u2014 double trouble","volume":"63","author":"Michniewicz","year":"2018","journal-title":"Adv Med Sci"},{"key":"R14-20250602","first-page":"846","article-title":"Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation (in Chinese)","volume":"42","author":"Sun","year":"2014","journal-title":"Chin J Cardiol"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jjcc.2014.11.001","article-title":"Clinical features and in-hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation","volume":"66","author":"Gonz\u00e1lez-Pacheco","year":"2015","journal-title":"J Cardiol"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur Heart J"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2018.09.031","article-title":"Usefulness of antithrombotic therapy in patients with atrial fibrillation and acute myocardial infarction","volume":"123","author":"Guimar\u00e3es","year":"2019","journal-title":"Am J Cardiol"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.jacc.2009.11.096","article-title":"Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation","volume":"55","author":"Tonino","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijcard.2014.04.002","article-title":"Prevalence and relative risk factors of atrial fibrillation in male coal miners in North China","volume":"174","author":"Yu","year":"2014","journal-title":"Int J Cardiol"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2018.05.131","article-title":"Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: results from a national stroke screening survey","volume":"271","author":"Wang","year":"2018","journal-title":"Int J Cardiol"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.12114","article-title":"Atrial fibrillation prevalence revisited","volume":"274","author":"Friberg","year":"2013","journal-title":"J Intern Med"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/eurheartj\/ehq472","article-title":"Primary prevention of stroke: blood pressure, lipids, and heart failure","volume":"32","author":"Endres","year":"2011","journal-title":"Eur Heart J"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.107.095497","article-title":"The burden of blood pressure-related disease: a neglected priority for global health","volume":"50","author":"Perkovic","year":"2007","journal-title":"Hypertension"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ajh.2007.59","article-title":"Blood pressure and risk of cardiovascular disease in Chinese men and women","volume":"21","author":"Gu","year":"2008","journal-title":"Am J Hypertens"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:08:06Z","timestamp":1748905686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,5]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002471","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,5]]}}}